RE: RE: A potential better deal :)13 Mar 2019 19:54
Yuen Low, analyst at Shore Capital, has a standard paragraph (that he has used repeatedly over dozens of times) that I can also repeat without looking at the text :) "All things considered, while Sirius is currently at development stage and still some years from becoming a cash flow-generating company, we believe that an investment in Sirius should become progressively de-risked and enjoy significant value uplift as it advances towards production."
However, this time (see article in proactiveinvestors, 13 March), his comments on the Alternative Proposal are more detailed containing a re-rated stock price projection (50p) after the stage 2 close and a 13.5 x current MC projection (US$18bn) over next few years:
Yuen Low, analyst at Shore Capital, in a note, said: “If all goes to plan, Sirius’s US$3.4bn to US$3.6bn Stage 2 financing will be successfully completed over the coming weeks.
“We expect this seminal achievement to catalyse a major re-rating of the shares, as it is effectively the key to unlocking Sirius’s vast value potential.”
Specifically, the Shore Capital analyst gives Sirius a 50p per share valuation (risked net present value) post-financing, versus a current share price just below 20p.
“Beyond that, while Sirius would still be some years from becoming cash generative, an investment in the company should become progressively de-risked and enjoy significant value uplift as it advances towards production, we believe,” Low added.
The analyst highlighted comparisons to sector peers and suggested that as Sirius approaches full production from the Yorkshire mine, it should upgrade significantly, to potentially have a market value of some US$18bn - based on an enterprise value to earnings (EV/EBITDA) rating of around x11).
Moreover, he asserts: “In other words, we see c.13.5x upside to the current market cap over the next few years.
“In our view, the current market cap also represents a material undervaluation in that, for any plausible acquirer, Sirius would not only be appreciably ‘needle-moving’ but should also improve said acquirer’s margins and EV/EBITDA rating.”